Professor of Neurological Surgery, UCSF
Orthopaedic Surgery
Dr. Michael Prados, MD
|
|
Give Review
Michael Prados works in the field of Orthopaedic Surgery. He graduated from Louisiana State University School of Medicine in New Orleans. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Dr. Michael Prados is a published physician. He has 36 papers published. The most current publication "Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience." He accepts Medicare.
Publications
- Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
- Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.
- Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotin...
- Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).
- Familial gliomas: cases in two pairs of brothers.
- Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group.
- Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.
- Plexiform neurofibromas, trial design, and the definitions of "progression" and "treatment failure".
- Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.
- "We will know it when we see it;" bevacizumab and glioblastoma.
- Phase II Trial of 7days on/7 days off temozolmide for recurrent high-grade glioma.
- A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.
- Targeting Wee1 for the treatment of pediatric high-grade gliomas.
- Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
- Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.
- The Somatic Genomic Landscape of Glioblastoma.
- Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
- Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report.
- Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children.
- Challenges With Defining Response to Antitumor Agents in Pediatric Neuro-Oncology: A Report From the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Gr...
- Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system.
- Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.
- Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts.
- Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept.
- Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein.
- Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
- Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.
- Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-cen...
- Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group.
- A prognostic gene expression signature in infratentorial ependymoma.
- An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing.
- Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
- Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
- Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.
- Gliosarcoma arising from an oligodendroglioma (oligosarcoma).
Schools
Louisiana State University School Of Medicine In Shreveport
Earl K Long Med Center
Med Center La New Orleans Lsu
Doctors Specialties
- Internal Medicine
- Orthopaedic Surgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Louisiana State University -
Louisiana State University School of Medicine in New Orleans
Hospital
-
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1467419432 | |
| NPPES Provider LastName | PRADOS | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 941432202 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 73.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467419432 |
| Last Name Of The Provider | PRADOS |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Michele Angers, MD |
|
|
Dr. Dean D. Schillinger, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan W. Leung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sansan M. Tin, MD |
|
Dr. Justin P. Fong, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gordon C. Lundy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kevin Bozic, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lamont J. Cardon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Serena S. Hu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Vedat Deviren, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Richard J. O'Donnell, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Lauren A. Hackney, MD
This Doctor is OpenDoctor Recommended.
|